PIK3CA and colorectal carcinoma: Indeed, PIK3CA is usually either mutated or amplified in several human cancers [55], including colorectal cancer (CRC) [56], breast [57], lung [58], gastric [59], prostate [60], and cervical cancer [61, 62].